ストックスクリーナーアプリを入手
13.60
3.27%
-0.46
アフターアワーズ：
13.67
0.07
+0.51%
前日終値:
$14.06
開ける：
$13.81
24時間の取引高:
153.83K
Relative Volume:
5.59
時価総額：
$360.62M
収益：
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
-6.21%
1か月 パフォーマンス:
+0.00%
6か月 パフォーマンス:
+0.00%
1年 パフォーマンス:
+0.00%
1日の値動き範囲:
$13.56
$13.83
1週間の範囲:
$13.56
$15.10
52週間の値動き範囲:
$13.56
$15.10
Carlsmed Inc Stock (CARL) Company Profile
CARL を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
13.60 | 372.82M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
281.35 | 46.44B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
54.89 | 9.80B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
91.06 | 8.39B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
57.33 | 11.01B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.59 | 6.44B | 906.14M | -52.62M | 89.62M | -0.3621 |
Carlsmed Inc (CARL) 最新ニュース
Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - Ortho Spine News
Carlsmed’s aprevo implants receive CMS NTAP for cervical fusion procedures - TipRanks
AI medtech firm Carlsmed prices $100.5M IPO - MSN
Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - Bloomberg
Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery - MarketScreener
Carlsmed announces completion of first aprevo cervical procedure - TipRanks
Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery - Ortho Spine News
Carlsmed’s Nasdaq Debut Gets $100.5M - San Diego Business Journal
Carlsmed Launches $100.5 Million Initial Public Offering - Global Legal Chronicle
Carlsbad-based medical technology company begins trading on Nasdaq - MSN
Latham & Watkins Advises on Carlsmed, Inc.’s US$100.5 Million Initial Public Offering - Latham & Watkins LLP
Carlsmed Insider Bought Shares Worth $899,985, According to a Recent SEC Filing - MarketScreener
Carlsmed director Philip Young buys $900k in shares By Investing.com - Investing.com Canada
Carlsmed (CARL) director Sidow buys $199,995 in shares - Investing.com Australia
Carlsmed (CARL) director Sidow buys $199,995 in shares By Investing.com - Investing.com Canada
Carlsmed director Philip Young buys $900k in shares - Investing.com
Carlsmed director Mittendorff buys $20 million in shares By Investing.com - Investing.com India
Carlsmed director Mittendorff buys $20 million in shares - Investing.com
Carlsmed, Inc. Completes Initial Public Offering - TipRanks
Carlsmed 6.7M share IPO priced at $15 per share - MSN
Carlsmed: Redefining Precision And Personalization In Spine Surgery With AI-Powered Aprevo - RTTNews
Carlsmed, Inc.(NasdaqGS: CARL) added to NASDAQ Composite Index - MarketScreener
Carlsmed: Spine Play Does Not Have My Backing Yet (NASDAQ:CARL) - Seeking Alpha
Carlsmed times IPO with reimbursement boon - Axios
Carlsmed Inc. (CARL): MedTech Makes Uninspiring Debut, Opens Flat and Trades Below Issue - Smartkarma
AI Spine Surgery Firm Carlsmed Shares Fall 3.3% After IPO - Bloomberg
Carlsmed begins trading on Nasdaq at $15 per share - Investing.com
Carlsmed (CARL): Assessing the Post-IPO Dip in a High-Growth MedTech Disruptor - AInvest
Carlsmed begins trading on Nasdaq at $15 per share By Investing.com - Investing.com Canada
Carlsmed, Inc Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Carlsmed, Inc Rings the Opening Bell - Nasdaq
Carlsmed Prices $100.5 Million IPO - MarketScreener
Carlsmed's $100.5M IPO: A Strategic Play in AI-Driven Personalized Spine Surgery - AInvest
Carlsmed Sets IPO Price at $15 per Share to Raise $100.5M - AInvest
Carlsmed raises USD 100.5M through IPO - Medical Buyer
Carlsmed launches IPO of 6.7 million shares priced $14-16 each - Investing.com Australia
Carlsmed prices IPO at $15 per share, to begin trading today - Investing.com Australia
Carlsmed's AI-Driven Spine Surgery Innovation and IPO Valuation: A Strategic Buy Opportunity for Long-Term Growth - AInvest
Carlsmed prices IPO at $15 per share, raising $100.5 million By Investing.com - Investing.com India
Carlsmed's AI-Driven Spine Surgery Platform and Its IPO Implications - AInvest
Carlsmed Inc (CARL) 財務データ
Carlsmed Inc (CARL) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
Carlsmed Inc (CARL) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Sidow Kevin | Director |
Jul 24 '25 |
Buy |
15.00 |
13,333 |
199,995 |
59,566 |
| Mittendorff Robert II | Director |
Jul 24 '25 |
Buy |
15.00 |
1,333,333 |
19,999,995 |
5,013,839 |
| ROOT JONATHAN D | Director |
Jul 24 '25 |
Buy |
15.00 |
466,666 |
6,999,990 |
483,999 |
| YOUNG PHILIP M | Director |
Jul 24 '25 |
Buy |
15.00 |
59,999 |
899,985 |
53,333 |
0.98%
0.00%
大文字化:
|
ボリューム (24 時間):